BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7407973)

  • 1. [Vitiligo and malignant melanoma].
    Moróc A; Král V; Duchková H; Richter J
    Cesk Dermatol; 1980 Aug; 55(4):284-5. PubMed ID: 7407973
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo associated with BCG-methanol extraction residue in malignant melanoma. Report of a case.
    Cohen Y; Haim S; Bartal A; Robinson E
    Dermatologica; 1979; 158(1):8-12. PubMed ID: 761693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More on vitiligo and malignant melanoma.
    Paslin D
    Arch Dermatol; 1980 May; 116(5):516-7. PubMed ID: 7377782
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.
    Rosenberg SA; White DE
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):81-4. PubMed ID: 8859727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Harnessing vitiligo for melanoma treatment].
    Merrick-Kenig E; Shoenfeld Y
    Harefuah; 2008 Jan; 147(1):33-7. PubMed ID: 18300621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant melanoma with secondary vitiligo].
    Agdal N; Christensen JD; Roed J
    Ugeskr Laeger; 1983 Nov; 145(47):3659-60. PubMed ID: 6659136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regional neurouegetative damage due to BCG. Apropos of a case of vitiligo appearing after vaccination with BCG].
    Gotti D
    Nuovi Ann Ig Microbiol; 1967; 18(4):326-33. PubMed ID: 5597627
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vitiligo and malignant melanoma with isolated lymph node manifestation].
    Nougué J; Bugat R; Martel P; Faugère JM
    Nouv Presse Med; 1982 Oct; 11(42):3138. PubMed ID: 7177831
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant melanoma and vitiligo: can radiotherapy shed light on the subject?
    Abood A; Saleh DB; Watt DA
    J Plast Reconstr Aesthet Surg; 2009 May; 62(5):e119-20. PubMed ID: 18938120
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N; Vaglini M; Rovini D; Orefice S; Marolda R; Veronesi U
    Minerva Med; 1982 Apr; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract]   [Full Text] [Related]  

  • 11. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation.
    Arpaia N; Cassano N; Vena GA
    Int J Dermatol; 2006 Aug; 45(8):952-6. PubMed ID: 16911383
    [No Abstract]   [Full Text] [Related]  

  • 12. Uveal malignant melanoma with leucoderma.
    Nirankari MS; Khanna KK; Mathur RP
    J All India Ophthalmol Soc; 1968 Jun; 16(2):63-6. PubMed ID: 5733909
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intralesional application of BCG].
    Kubíková M; Richter J; Hrivnáková J; Duchková H
    Cesk Dermatol; 1980 Aug; 55(4):280-1. PubMed ID: 7407971
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
    Caplan SE; Kauffman CL
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.
    Luiten RM; Kueter EW; Mooi W; Gallee MP; Rankin EM; Gerritsen WR; Clift SM; Nooijen WJ; Weder P; van de Kasteele WF; Sein J; van den Berk PC; Nieweg OE; Berns AM; Spits H; de Gast GC
    J Clin Oncol; 2005 Dec; 23(35):8978-91. PubMed ID: 16260696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma of the choroid with vitiligo.
    Pai HV; Satish KR; Maravoor P
    Indian J Ophthalmol; 2001 Mar; 49(1):51-3. PubMed ID: 15887717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo associated with malignant melanoma and lupus erythematosus.
    Gül U; Kiliç A; Tulunay O; Kaygusuz G
    J Dermatol; 2007 Feb; 34(2):142-5. PubMed ID: 17239155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo: a good prognostic factor in melanoma?
    Cunha D; Pacheco FA; Cardoso J
    Dermatol Online J; 2009 Feb; 15(2):15. PubMed ID: 19336032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: BCG treatment of malignant melanoma.
    Can Med Assoc J; 1974 Feb; 110(3):258. PubMed ID: 4812144
    [No Abstract]   [Full Text] [Related]  

  • 20. Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?
    Ram M; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Sep; 1110():410-25. PubMed ID: 17911456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.